A Study to Learn How Safe and Tolerable Vonsetamig is in Adult Patients With Chronic Kidney Disease (CKD) Who Need Kidney Transplantation and Are Highly Sensitized to Human Leukocyte Antigen (HLA)
Clinical trial NCT05092347 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05092347
- Sponsor
- Regeneron Pharmaceuticals
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-02
- Primary completion
- 2027-11-22
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.